Investing Profile

Eric Anschutz


Experienced angel with biotech focus. Selective deal flow supported by quantitative evaluation system. Proven, exit-driven results over 15+ years. Bike lover. Francisco, California
Photo of Eric Anschutz

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
$10K - $250K
CompanyStageDateRound SizeTotal Raised
Attivare Therapeutics
SeedJun 2021$1
Co-investors: Maximilian Winter (Harmonix Fund)
Primordial Genetics
Seed RoundFeb 2021$1
Seed RoundFeb 2021$6M
Seed RoundOct 2020$6M
Seed RoundAug 2020$2.5M
Co-investors: Wes Selke (Better Ventures), Jordan Fliegel (Techstars)
Seed RoundMay 2019$4.5M
Seed RoundFeb 2017
Co-investors: Phil Libin (General Catalyst), Nate Dalton (Daybreak Partners), Justin Rosenstein
Venture RoundOct 2018
SeedMar 2018$1
Co-investors: Tony Fadell (Future Shape), Arvind Gupta (SOSV), Seth Berman (Susa Ventures), Po Bronson (SOSV)
Notable Labs
Series BSep 2017$15M
Co-investors: John Kim (AMASIA), Ramanan Raghavendran (AMASIA), Milad Alucozai (BoxOne Ventures), John Noonan (Lifeforce Capital), Chris Sklarin (Alumni Ventures Group), Anton Simunovic (Alumni Ventures Group), Charlie Pinto (Bling Capital), Stefano Bernardi (Atomico), Ross Blankenship (Angel Kings), Kevin Mahaffey (SNR), Jim Kim (formation|8)
Twist Bioscience
Series DMar 2017$33M
Series DJan 2016$61M
Co-investors: Omri Amirav Drory (NFX), Eric Moessinger (NanoDimension), Paul Conley (Paladin Capital Group), Nick Naclerio (Illumina Ventures), Gibb Witham (Paladin Capital Group), Boris Nikolic (Biomatics Capital Partners), rich simoni
Biotech, Synthetic Biology, Bicycles, Medical Bioinformatics, Genomics, Genetic Testing, Biotechnology, DNA/RNA, Microbiome, Quantified Self, Medical Devices, Internet of Things, Pharmaceuticals, Bio-Pharma